What are the major opportunities in the Veterinary Intravenous (IV) Solutions market? What are the strategies for the Veterinary Intravenous (IV) Solutions market?

For detailed insights on the major opportunities and strategies in the Veterinary Intravenous (IV) Solutions market, Read More

How does the Veterinary Intravenous (IV) Solutions market relate to the overall economy and other similar markets?

For detailed insights on Veterinary Intravenous (IV) Solutions's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Veterinary Intravenous (IV) Solutions market growth? SWOT analysis of the Veterinary Intravenous (IV) Solutions market.

For detailed insights on the key dynamics influencing the Veterinary Intravenous (IV) Solutions market growth and SWOT analysis of the Veterinary Intravenous (IV) Solutions industry, Read More

Veterinary Intravenous (IV) Solutions Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Veterinary Intravenous (IV) Solutions Market Report 2026

Name: Veterinary Intravenous (IV) Solutions Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product (Isotonic Crystalloids, Dextrose Solutions, Synthetic Colloids, Natural Colloids, Parenteral Nutrition), By Animal Type (Companion Animals, Production Animals), By End-User (Veterinary Hospitals And Clinics, Research Institutes, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Veterinary Intravenous (IV) Solutions Market Overview

• Veterinary Intravenous (IV) Solutions market size has reached to $1.62 billion in 2025

• Expected to grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%

• Growth Driver: Rising Prevalence Of Animal Diseases Fuels Market Growth

• Market Trend: Advancements In Veterinary IV Solutions For Respiratory Infections

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Veterinary Intravenous (IV) Solutions Market?

Veterinary intravenous (IV) solutions are sterile fluids administered directly into the bloodstream of animals through a vein, typically via an IV catheter. These solutions are used in veterinary medicine to treat dehydration and electrolyte imbalances, deliver medications, or provide nutrients. Veterinary intravenous (IV) solutions are essential for maintaining or restoring the proper fluid and electrolyte balance in animals, especially in illness, surgery, or trauma cases.

The main product types of veterinary intravenous (iv) solutions are isotonic crystalloids, dextrose solutions, synthetic colloids, natural colloids, and parenteral nutrition. Isotonic crystalloids are intravenous (IV) fluids that have the same concentration of solutes as the blood, helping to maintain fluid balance in the body. The various animal types include companion animals and production animals. These are used by various end-users such as veterinary hospitals and clinics, research institutes, and others.

Veterinary Intravenous (IV) Solutions market report bar graph

What Is The Veterinary Intravenous (IV) Solutions Market Size and Share 2026?

The veterinary intravenous (iv) solutions market size has grown strongly in recent years. It will grow from $1.62 billion in 2025 to $1.75 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising prevalence of dehydration and electrolyte imbalances in animals, growth in companion animal population, increasing number of veterinary hospitals and clinics, adoption of conventional iv solutions, technological advancements in veterinary fluid therapy.

What Is The Veterinary Intravenous (IV) Solutions Market Growth Forecast?

The veterinary intravenous (iv) solutions market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to growing demand for advanced isotonic and colloid solutions, increasing adoption of parenteral nutrition in veterinary care, development of specialized iv solutions for critical care, rising awareness of fluid therapy benefits, expansion of veterinary emergency and critical care services. Major trends in the forecast period include development of advanced isotonic and balanced electrolyte solutions, increased use of synthetic and natural colloids, growth in parenteral nutrition solutions for companion and production animals, adoption of pre-mixed and ready-to-use iv solutions, expansion of veterinary critical care and emergency fluid therapy.

Book your 30 minutes free consultation with our research experts

Global Veterinary Intravenous (IV) Solutions Market Segmentation

1) By Product: Isotonic Crystalloids, Dextrose Solutions, Synthetic Colloids, Natural Colloids, Parenteral Nutrition

2) By Animal Type: Companion Animals, Production Animals

3) By End-User: Veterinary Hospitals And Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Isotonic Crystalloids: Normal Saline (0.9% NaCl), Lactated Ringer's Solution, Dextrose In Water (D5W), Ringer's Solution, Balanced Electrolyte Solutions

2) By Dextrose Solutions: Dextrose 5% In Water (D5W), Dextrose 10% In Water (D10W), Dextrose 20% In Water (D20W), Dextrose 50% In Water (D50W)

3) By Synthetic Colloids: Hydroxyethyl Starch (HES), Dextran, Gelatins

4) By Natural Colloids: Albumin, Fresh Frozen Plasma (FFP), Blood Products

5) By Parenteral Nutrition: Total Parenteral Nutrition (TPN) Solutions, Partial Parenteral Nutrition Solutions, Lipid Emulsions, Amino Acid Solutions

What Are The Drivers Of The Veterinary Intravenous (IV) Solutions Market?

The increase in the prevalence of various animal diseases is expected to propel the growth of the veterinary intravenous (IV) solutions market going forward. Animal diseases refer to conditions or disorders that impair the health and function of animals. The common animal diseases are anthrax, leptospirosis, rabies, canine distemper, heartworm disease, and more. The increase in the prevalence of various animal diseases is driven by several factors, including intensive farming practices, wildlife encroachment, and antibiotic resistance. Veterinary intravenous solutions are essential for rehydrating animals affected by dehydration-inducing diseases, such as gastroenteritis or severe infections, by ensuring optimal hydration and supporting overall health outcomes. For instance, in May 2025, according to the World Organisation for Animal Health (WOAH), a France-based intergovernmental animal health body, outbreaks of avian influenza in mammals more than doubled last year compared with 2023, with 1,022 reported outbreaks across 55 countries compared to 459 outbreaks in 2023, indicating a significant rise in disease prevalence across multiple species. Therefore, the increase in the prevalence of various animal diseases is driving the growth of the veterinary intravenous (IV) solutions industry.

The increasing spending on animal health products is expected to propel the growth of the veterinary intravenous (IV) solutions market going forward. Animal health products refer to medications, supplements, and treatments used to maintain or improve the health and well-being of animals. The increasing spending on animal health products is driven by factors such as rising pet ownership, growing awareness of animal health, advancements in veterinary care, and the need for better disease prevention and treatment options. Veterinarian IV solutions help to increase spending on animal health products by meeting urgent medical demands and advancing veterinary care. For instance, in March 2024, according to the Republic of Estonia Agency of Medicines, an Estonia-based regulatory authority, in 2023, the veterinary medicinal products market increased by 6.9%, reaching $20.54 million (18.6 million euros) up from USD 19.21 million (17.40 million euros) in 2022. Therefore, the increasing spending on animal health products is driving the growth of the veterinary intravenous (IV) solutions industry.

Key Players In The Global Veterinary Intravenous (IV) Solutions Market

Major companies operating in the veterinary intravenous (iv) solutions market are Merck & Co. Inc., Baxter International Inc., Zoetis Inc., Fresenius Kabi AG, Elanco Animal Health Incorporated, B. Braun Melsungen AG, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol SA, Norbrook Laboratories Limited, Ceva Santé Animale, Revival Animal Health Inc., Aromor Animal Health, Jorgensen Laboratories LLC, Pharmacosmos AS, Sykes Veterinary International Pty Ltd., Rusoma Laboratories Private Limited, Patterson Companies Inc., NexGen Veterinary, Soxa Formulations & Research Pvt. Ltd

Global Veterinary Intravenous (IV) Solutions Market Trends and Insights

Major companies operating in the veterinary intravenous (IV) solutions market are focusing on developing advanced products such as fluoroquinolone to help improve efficacy and safety profiles. Fluoroquinolones are a powerful class of antibiotics used in human and veterinary medicine to treat various bacterial infections that can be managed carefully to minimize the risk of resistance and side effects. For instance, in April 2024, Elanco, a US-based pharmaceutical company, announced Pradalex, a pradofloxacin injection solution approved by the US Food and Drug Administration (FDA), a US-based health organization. The approval for swine is for the treatment of swine respiratory disease (SRD) associated with bordetella bronchiseptica, Glaesserella (Haemophilus) parasuis, Pasteurella multocida, streptococcus suis, and mycoplasma hyopneumoniae. Pradalex is a 3rd generation fluoroquinolone, ranked as a critically important antimicrobial. The drug's label includes a statement that it should be used only after considering other non-fluoroquinolone therapeutic options.

Need data on a specific region in this market?

Request Regional Data

Regional Outlook

North America was the largest region in the veterinary intravenous (IV) solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Veterinary Intravenous (IV) Solutions Market?

The veterinary intravenous (IV) solutions market consists of sales of hypertonic solutions, isotonic solutions, and hypertonic solutions. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Veterinary Intravenous (IV) Solutions Market Report 2026?

The veterinary intravenous (iv) solutions market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary intravenous (iv) solutions industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Veterinary Intravenous (IV) Solutions Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$1.75 billion
Revenue Forecast In 2035	$2.36 billion
Growth Rate	CAGR of 8.1% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product, Animal Type, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Merck & Co. Inc., Baxter International Inc., Zoetis Inc., Fresenius Kabi AG, Elanco Animal Health Incorporated, B. Braun Melsungen AG, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol SA, Norbrook Laboratories Limited, Ceva Santé Animale, Revival Animal Health Inc., Aromor Animal Health, Jorgensen Laboratories LLC, Pharmacosmos AS, Sykes Veterinary International Pty Ltd., Rusoma Laboratories Private Limited, Patterson Companies Inc., NexGen Veterinary, Soxa Formulations & Research Pvt. Ltd
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Veterinary Intravenous (IV) Solutions Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Veterinary Intravenous (IV) Solutions Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Veterinary Intravenous (IV) Solutions Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Veterinary Intravenous (IV) Solutions Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Industry 4.0 & Intelligent Manufacturing

4.1.2 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.3 Biotechnology, Genomics & Precision Medicine

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Digitalization, Cloud, Big Data & Cybersecurity

4.2. Major Trends

4.2.1 Development Of Advanced Isotonic And Balanced Electrolyte Solutions

4.2.2 Increased Use Of Synthetic And Natural Colloids

4.2.3 Growth In Parenteral Nutrition Solutions For Companion And Production Animals

4.2.4 Adoption Of Pre-Mixed And Ready-To-Use Iv Solutions

4.2.5 Expansion Of Veterinary Critical Care And Emergency Fluid Therapy

5. Veterinary Intravenous (IV) Solutions Market Analysis Of End Use Industries

5.1 Veterinary Hospitals And Clinics

5.2 Research Institutes

5.3 Animal Emergency And Critical Care Centers

5.4 Veterinary Specialty Clinics

5.5 Pharmaceutical And Animal Health Companies

6. Veterinary Intravenous (IV) Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Veterinary Intravenous (IV) Solutions Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Veterinary Intravenous (IV) Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Veterinary Intravenous (IV) Solutions Market Size, Comparisons And Growth Rate Analysis

7.3. Global Veterinary Intravenous (IV) Solutions Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Veterinary Intravenous (IV) Solutions Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Veterinary Intravenous (IV) Solutions Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Veterinary Intravenous (IV) Solutions Market Segmentation

9.1. Global Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Isotonic Crystalloids, Dextrose Solutions, Synthetic Colloids, Natural Colloids, Parenteral Nutrition

9.2. Global Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Companion Animals, Production Animals

9.3. Global Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Veterinary Hospitals And Clinics, Research Institutes, Other End-Users

9.4. Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Isotonic Crystalloids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Normal Saline (0.9% NaCl), Lactated Ringer's Solution, Dextrose In Water (D5W), Ringer's Solution, Balanced Electrolyte Solutions

9.5. Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Dextrose Solutions, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Dextrose 5% In Water (D5W), Dextrose 10% In Water (D10W), Dextrose 20% In Water (D20W), Dextrose 50% In Water (D50W)

9.6. Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Synthetic Colloids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hydroxyethyl Starch (HES), Dextran, Gelatins

9.7. Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Natural Colloids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Albumin, Fresh Frozen Plasma (FFP), Blood Products

9.8. Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Parenteral Nutrition, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Total Parenteral Nutrition (TPN) Solutions, Partial Parenteral Nutrition Solutions, Lipid Emulsions, Amino Acid Solutions

10. Veterinary Intravenous (IV) Solutions Market Regional And Country Analysis

10.1. Global Veterinary Intravenous (IV) Solutions Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Veterinary Intravenous (IV) Solutions Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Veterinary Intravenous (IV) Solutions Market

11.1. Asia-Pacific Veterinary Intravenous (IV) Solutions Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Veterinary Intravenous (IV) Solutions Market

12.1. China Veterinary Intravenous (IV) Solutions Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Veterinary Intravenous (IV) Solutions Market

13.1. India Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Veterinary Intravenous (IV) Solutions Market

14.1. Japan Veterinary Intravenous (IV) Solutions Market Overview

14.2. Japan Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Veterinary Intravenous (IV) Solutions Market

15.1. Australia Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Veterinary Intravenous (IV) Solutions Market

16.1. Indonesia Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Veterinary Intravenous (IV) Solutions Market

17.1. South Korea Veterinary Intravenous (IV) Solutions Market Overview

17.2. South Korea Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Veterinary Intravenous (IV) Solutions Market

18.1. Taiwan Veterinary Intravenous (IV) Solutions Market Overview

18.2. Taiwan Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Veterinary Intravenous (IV) Solutions Market

19.1. South East Asia Veterinary Intravenous (IV) Solutions Market Overview

19.2. South East Asia Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Veterinary Intravenous (IV) Solutions Market

20.1. Western Europe Veterinary Intravenous (IV) Solutions Market Overview

20.2. Western Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Veterinary Intravenous (IV) Solutions Market

21.1. UK Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Veterinary Intravenous (IV) Solutions Market

22.1. Germany Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Veterinary Intravenous (IV) Solutions Market

23.1. France Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Veterinary Intravenous (IV) Solutions Market

24.1. Italy Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Veterinary Intravenous (IV) Solutions Market

25.1. Spain Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Veterinary Intravenous (IV) Solutions Market

26.1. Eastern Europe Veterinary Intravenous (IV) Solutions Market Overview

26.2. Eastern Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Veterinary Intravenous (IV) Solutions Market

27.1. Russia Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Veterinary Intravenous (IV) Solutions Market

28.1. North America Veterinary Intravenous (IV) Solutions Market Overview

28.2. North America Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Veterinary Intravenous (IV) Solutions Market

29.1. USA Veterinary Intravenous (IV) Solutions Market Overview

29.2. USA Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Veterinary Intravenous (IV) Solutions Market

30.1. Canada Veterinary Intravenous (IV) Solutions Market Overview

30.2. Canada Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Veterinary Intravenous (IV) Solutions Market

31.1. South America Veterinary Intravenous (IV) Solutions Market Overview

31.2. South America Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Veterinary Intravenous (IV) Solutions Market

32.1. Brazil Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Veterinary Intravenous (IV) Solutions Market

33.1. Middle East Veterinary Intravenous (IV) Solutions Market Overview

33.2. Middle East Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Veterinary Intravenous (IV) Solutions Market

34.1. Africa Veterinary Intravenous (IV) Solutions Market Overview

34.2. Africa Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Veterinary Intravenous (IV) Solutions Market Regulatory and Investment Landscape

36. Veterinary Intravenous (IV) Solutions Market Competitive Landscape And Company Profiles

36.1. Veterinary Intravenous (IV) Solutions Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Veterinary Intravenous (IV) Solutions Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Veterinary Intravenous (IV) Solutions Market Company Profiles

36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis

37. Veterinary Intravenous (IV) Solutions Market Other Major And Innovative Companies

B. Braun Melsungen AG, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol SA, Norbrook Laboratories Limited, Ceva Santé Animale, Revival Animal Health Inc., Aromor Animal Health, Jorgensen Laboratories LLC, Pharmacosmos AS, Sykes Veterinary International Pty Ltd., Rusoma Laboratories Private Limited, Patterson Companies Inc., NexGen Veterinary, Soxa Formulations & Research Pvt. Ltd

38. Global Veterinary Intravenous (IV) Solutions Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Veterinary Intravenous (IV) Solutions Market

40. Veterinary Intravenous (IV) Solutions Market High Potential Countries, Segments and Strategies

40.1 Veterinary Intravenous (IV) Solutions Market In 2030 - Countries Offering Most New Opportunities

40.2 Veterinary Intravenous (IV) Solutions Market In 2030 - Segments Offering Most New Opportunities

40.3 Veterinary Intravenous (IV) Solutions Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Veterinary Intravenous (IV) Solutions Market, Overview Of Key Products - Product Examples

Table 2: Global Veterinary Intravenous (IV) Solutions Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Veterinary Intravenous (IV) Solutions Market, Supply Chain Analysis

Table 4: Global Veterinary Intravenous (IV) Solutions Market, Major Raw Material Providers

Table 5: Global Veterinary Intravenous (IV) Solutions Market, Major Resource Providers

Table 6: Global Veterinary Intravenous (IV) Solutions Market, Major Manufacturers (Suppliers)

Table 7: Global Veterinary Intravenous (IV) Solutions Market, Major Distributors And Channel Partners

Table 8: Global Veterinary Intravenous (IV) Solutions Market, Key Technologies & Future Trends

Table 9: Global Veterinary Intravenous (IV) Solutions Market, Major Trends

Table 10: Global Veterinary Intravenous (IV) Solutions Market, Major End Users

Table 11: Global Veterinary Intravenous (IV) Solutions Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Veterinary Intravenous (IV) Solutions Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Veterinary Intravenous (IV) Solutions Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Veterinary Intravenous (IV) Solutions Market - TAM, US$ Billion, 2025

Table 15: Global Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Isotonic Crystalloids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Dextrose Solutions, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Synthetic Colloids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Natural Colloids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Parenteral Nutrition, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Veterinary Intravenous (IV) Solutions Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Veterinary Intravenous (IV) Solutions Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Veterinary Intravenous (IV) Solutions Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Veterinary Intravenous (IV) Solutions Market - Company Scoring Matrix

Table 99: Merck & Co. Inc. Financial Performance

Table 100: Baxter International Inc. Financial Performance

Table 101: Zoetis Inc. Financial Performance

Table 102: Fresenius Kabi AG Financial Performance

Table 103: Elanco Animal Health Incorporated Financial Performance

Table 104: Global Veterinary Intravenous (IV) Solutions Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Veterinary Intravenous (IV) Solutions Market, Competitive Dashboard

Table 106: Global Veterinary Intravenous (IV) Solutions Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Veterinary Intravenous (IV) Solutions Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Table 108: Global, Veterinary Intravenous (IV) Solutions Market Size Gain ($ Billion), Segmentation By Animal Type, 2025 – 2030

Table 109: Global, Veterinary Intravenous (IV) Solutions Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

Figure 1: Global Veterinary Intravenous (IV) Solutions Market, Overview Of Key Products - Product Examples

Figure 2: Global Veterinary Intravenous (IV) Solutions Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Veterinary Intravenous (IV) Solutions Market, Supply Chain Analysis

Figure 4: Global Veterinary Intravenous (IV) Solutions Market, Major Raw Material Providers

Figure 5: Global Veterinary Intravenous (IV) Solutions Market, Major Resource Providers

Figure 6: Global Veterinary Intravenous (IV) Solutions Market, Major Manufacturers (Suppliers)

Figure 7: Global Veterinary Intravenous (IV) Solutions Market, Major Distributors And Channel Partners

Figure 8: Global Veterinary Intravenous (IV) Solutions Market, Key Technologies & Future Trends

Figure 9: Global Veterinary Intravenous (IV) Solutions Market, Major Trends

Figure 10: Global Veterinary Intravenous (IV) Solutions Market, Major End Users

Figure 11: Global Veterinary Intravenous (IV) Solutions Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Veterinary Intravenous (IV) Solutions Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Veterinary Intravenous (IV) Solutions Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Veterinary Intravenous (IV) Solutions Market - TAM, US$ Billion, 2025

Figure 15: Global Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Isotonic Crystalloids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Dextrose Solutions, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Synthetic Colloids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Natural Colloids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Parenteral Nutrition, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Veterinary Intravenous (IV) Solutions Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Veterinary Intravenous (IV) Solutions Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Veterinary Intravenous (IV) Solutions Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Veterinary Intravenous (IV) Solutions Market - Company Scoring Matrix

Figure 99: Merck & Co. Inc. Financial Performance

Figure 100: Baxter International Inc. Financial Performance

Figure 101: Zoetis Inc. Financial Performance

Figure 102: Fresenius Kabi AG Financial Performance

Figure 103: Elanco Animal Health Incorporated Financial Performance

Figure 104: Global Veterinary Intravenous (IV) Solutions Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Veterinary Intravenous (IV) Solutions Market, Competitive Dashboard

Figure 106: Global Veterinary Intravenous (IV) Solutions Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Veterinary Intravenous (IV) Solutions Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Figure 108: Global, Veterinary Intravenous (IV) Solutions Market Size Gain ($ Billion), Segmentation By Animal Type, 2025 – 2030

Figure 109: Global, Veterinary Intravenous (IV) Solutions Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Industry Forecast: Canine Atopic Dermatitis Market to Generate $4.09 Billion Revenue by 2029

Veterinary Ophthalmology Equipment Market Revenue Outlook: Strategic Insights and Forecast to 2029

Global Animal Antibiotics and Antimicrobials Market Projected to Reach $7.48 Billion by 2029 at a CAGR of 7.3%

$51.83 Billion Forecast for Animal Based Protein Supplements Market by 2029, Backed by Demand and Innovation

Aquafeed Additives Market Forecast Reaching $2.43 Billion by 2029 at 6.9% CAGR

Cattle Feed & Feed Additives Market Valuation Expected To Reach $84.77 Billion By 2029, Growing At A Rate Of 6.2%

Strong CAGR to Propel in the Companion Animal Arthritis Market and Beyond upto $6 Billion by 2029

Farm Animal Healthcare Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Veterinary Stereotactic Radiosurgery System Market Report 2026 - Global Outlook – By Product (Microsurgical Instrumentation, Imaging And Visualization Systems, Radiation Therapy Systems And Software), By Modality (Gamma ...

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report 2026 - Global Outlook – By Product (Antiparasitic, Anti-Infectives, Vaccines, NSAIDs), By Service Type (In House, Contract Outsourcing), By Synthes...

Veterinary Dermatology Drugs Market Report 2026 - Global Outlook – By Product Type (Antifungal Drugs, Antibacterial Drugs, Antiparasitic Drugs), By Animal Type (Companion Animal, Livestock Animal), By Drug Indication (Pa...

Veterinary Dietary Supplements Market Report 2026 - Global Outlook – By Type (Omega 3 Fatty Acids, Proteins And Peptides, CBD, Multivitamins And Minerals, Probiotics And Prebiotics, Other Types), By Dosage Form (Tablets ...

Veterinary Medicine Market Report 2026 - Global Outlook – By Product (Drugs, Vaccines, Medical Feed Additives), By Animal Type (Companion Animals, Livestock Animals), By Route Of Administration (Oral Route, Parental Rout...

Veterinary Biologics Market Report 2026 - Global Outlook – By Product (Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products), By Disease Type (Bluetongue, Foot And Mouth Disease, Brucell...

Veterinary Hematology Analyzers Market Report 2026 - Global Outlook – By Product Type (Table Top Analyzer, Point Of Care Analyzer), By Animal Type (Companion Animal, Livestock Animals), By Analysis Parameter (2-Part WBC ...

Frequently Asked Questions

How big is the Veterinary Intravenous (IV) Solutions Market?

The Veterinary Intravenous (IV) Solutions market was valued at $1.62 billion in 2025, increased to $1.75 billion in 2026, and is projected to reach $2.36 billion by 2030.

What is the Veterinary Intravenous (IV) Solutions market growth?

The global Veterinary Intravenous (IV) Solutions market is expected to grow at a CAGR of 7.7% from 2026 to 2035 to reach $2.36 billion by 2035.

Who are the key players in Veterinary Intravenous (IV) Solutions market?

Some Key Players in the Veterinary Intravenous (IV) Solutions market Include, Merck & Co. Inc., Baxter International Inc., Zoetis Inc., Fresenius Kabi AG, Elanco Animal Health Incorporated, B. Braun Melsungen AG, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol SA, Norbrook Laboratories Limited, Ceva Santé Animale, Revival Animal Health Inc., Aromor Animal Health, Jorgensen Laboratories LLC, Pharmacosmos AS, Sykes Veterinary International Pty Ltd., Rusoma Laboratories Private Limited, Patterson Companies Inc., NexGen Veterinary, Soxa Formulations & Research Pvt. Ltd .

What is the anticipated growth trend for the Veterinary Intravenous (IV) Solutions market?

Major trend in this market includes: Advancements In Veterinary IV Solutions For Respiratory Infections. For further insights on this market. request a sample here

Which region has the most growth potential in the Veterinary Intravenous (IV) Solutions market?

North America was the largest region in the veterinary intravenous (IV) solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary intravenous (iv) solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.